The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 17, 2026
Filed:
Dec. 14, 2020
Applicant:
Tandem Diabetes Care, Inc., San Diego, CA (US);
Inventors:
Sean Saint, San Diego, CA (US);
Michael Rosinko, Anaheim, CA (US);
Assignee:
TANDEM DIABETES CARE, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61M 5/14244 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); A61M 2005/14208 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2209/01 (2013.01); A61M 2230/005 (2013.01); A61M 2230/201 (2013.01);
Abstract
A portable infusion pump can communicate with glucose monitor, such as a continuous glucose monitor (CGM), to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Due to potential unreliability in the correlation of the CGM data to the user's actual blood glucose level, risk mitigation can be employed to limit the amount of extra insulin that can be delivered by the pump in response to the CGM data.